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Abstract: The ascending fibers releasing norepinephrine and acetylcholine 
are highly active during wakefulness. In contrast, during rapid-eyemovement 
sleep, the neocortical tone is sustained mainly by acetylcholine. 
By comparing the different physiological features of the norepinephrine 
and acetylcholine systems in the light of the GANE (glutamate amplifies 
noradrenergic effects) model, we suggest how to interpret some functional 
differences between waking and rapid-eye-movement sleep. 
Regulation of neocortical circuits by ascending regulatory systems 
involves all of the classic neurotransmitters. Most of the nuclei 
located in the brainstem, hypothalamus, and basal forebrain not 
only are reciprocally connected, but also send direct projections 
to the neocortex (Jones 2011; Saper et al. 2010; Steriade & 
McCarley 2005). The same applies to release by the hypothalamic 
nuclei of neuropeptides such as orexin/hypocretin in wakefulness 
and melanin-concentrating hormone (MCH) in rapid-eye-movement 
(REM) sleep (Aracri et al. 2015; Jones & Hassani 2008; 
Monti et al. 2013; and references therein). As a first approximation, 
these bewildering intricacies can be simplified by focusing 
on the balance in activity between noradrenergic and cholinergic 
nuclei, which are crucial regulators of arousal and cognition (e.g., 
Constantinople & Bruno 2011; Schmidt et al. 2013). Both project 
varicose fibers that widely innervate the neocortex, and their 
global effects are excitatory. During wakefulness, high levels of 
norepinephrine (NE) and acetylcholine (ACh) cooperate in regulating 
arousal and cognitive processes. However, although cholinergic 
transmission is certainly implicated in synaptic plasticity 
(e.g., Berg 2011), the physiological action of NE is thought to 
be more persistent and more closely related to memory retention 
and consolidation (e.g., Constantinople & Bruno 2011; McGaugh 
2013; Schmidt et al. 2013). The activity of noradrenergic and cholinergic 
neurons decreases during non-REM (NREM) sleep, 
whereas in REM sleep, ACh release increases again, whereas 
NE activity remains low (Datta 2010; Lee et al. 2005; Saper 
et al. 2010; Takahashi et al. 2010) (Fig. 1). The fact that neocortex 
activation in REM sleep is sustained mainly by ACh is a further 
indication that the cholinergic tone is more directly related to consciousness 
and executive functions. In fact, the role of REM sleep 
in memory consolidation remains controversial (Ackermann & 
Rasch 2014; Rasch & Born 2013). 
Does the GANE model help suggest possible explanations of 
the different functional consequences of activating these regulatory 
systems during brain states? A first central assumption is 
that, under strong neuronal activation, spillover glutamate stimulates 
nearby NE varicosities in an N-methyl-D-aspartate 
(NMDA) receptor-mediated manner. By activating low-affinity 
β-adrenoreceptors, high NE release would stimulate neuronal 
excitability, as well as glutamatergic terminals, thus constituting 
activity “hotspots” that effectively amplify inputs with high 
  
Figure 1 (Becchetti & Amadeo). Cholinergic and noradrenergic 
activity through the sleep–wake cycle. The scheme provides a 
qualitative comparison of the activity of the ascending 
cholinergic and noradrenergic projections, with no pretension of 
quantitative precision. AU=arbitrary units. 
priority under phasic arousal. Are such hotspots possible in the 
cholinergic system? Not much is known about the glutamatergic 
regulation of ACh release, but evidence does exist of ionotropic 
glutamate receptors regulating cholinergic terminals in the neocortex 
(Ghersi et al. 2003; Parikh et al. 2008). Hence, it is conceivable 
that spillover glutamate also stimulates cholinergic 
fibers. Because it is well known that ACh increases glutamate 
release (Marchi & Grilli 2010), a positive feedback loop could 
generate local ACh hotspots, analogous to those hypothesized 
by Mather and colleagues. 
A second tenet of the GANE model is that the low-threshold 
α2-adrenoreceptors, by responding to low NE concentrations, 
would inhibit glutamate release in pathways implicated in low priority 
signaling, under aroused conditions. In this respect, the cholinergic 
system presents several differences compared with the 
noradrenergic. In particular: (1) cholinergic fibers form both 
well-differentiated point-to-point synapses and axon varicosities 
that sustain diffuse ACh release (Dani & Bertrand 2007); and 
(2) ACh activates both metabotropic (muscarinic, mAChRs) and 
ionotropic (nicotinic, nAChR) receptors. In prefrontal regions, 
M1 mAChRs are widespread and produce excitatory effects 
related to working memory through different cellular mechanisms 
(e.g., McCormick & Prince 1986; Gulledge et al. 2009; Proulx 
et al. 2014). Their EC50 for ACh is in the low μM range. On the 
other hand, nAChRs can be divided into two functional classes 
(Dani & Bertrand 2007). Heteromeric nAChRs have high affinity 
for ACh (with EC50 in the μM range), relatively low permeability 
to Ca2+ (PCa), and slow desensitization in the presence of agonist. 
Homomeric nAChRs have high PCa (in the order of the one 
displayed by NMDA receptors), but low affinity for ACh 
(EC50 ≈ 200 μM), and quick desensitization kinetics. A striking 
difference with NE transmission is immediately apparent. The 
long-term effects on synaptic consolidation are thought to 
depend on Ca2+ signals. However, within the putative ACh 
hotspots, the efficacy of high-PCa homomeric receptors would 
be blunted by quick desensitization. High ACh concentrations 
would also tend to desensitize heteromeric nAChRs. This would 
prevent sustained Ca2+ entry through nAChRs as well as by 
nAChR-dependent activation of glutamate release, and thus of 
NMDA receptors. Therefore, it seems unlikely that ACh hotspots 
can produce long-term cellular effects considerably different from 
those produced by lower ACh concentrations. 
In summary, by following up the GANE model reasoning, one 
is led to conclude that low and high concentrations of NE and 
ACh produce distinct functional effects on neocortical networks. 
Low to moderate ACh release sustains global neocortex arousal 
in both wakefulness and REM sleep. However, in the absence of 
NE activity (as in REM sleep), cholinergic activity is unable to 
yield long-term synaptic changes, such as those implicated in 
memory retention, which would partly explain the well-known 
difficulty of recalling oneiric activity. Instead, high levels of 
ACh seem more able to shape the rapid synaptic responses implicated 
in executive functions, as the quick kinetics of the lowaffinity 
nicotinic ACh receptors would suggest. We believe that 
deeper functional studies of the interplay between the ascending 
regulatory systems, led by heuristic models such as GANE, will 
greatly lead to progress in understanding the physiological 
basis of cognition. 
